T · 3405.T · CHEMICALS
Kuraray Co., Ltd. (3405.T) intrinsic value and stock valuation
$1,748.50as of 2026-11-21 · Mkt cap 481.17B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Kuraray Co., Ltd. DCF and intrinsic value
InvestorsCraft values 3405.T with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from 3405.T’s statements →
Kuraray Co., Ltd. Graham Number
Graham Number: $1,126.39d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $808.4B | $826.9B | $780.9B | $756.4B | $629.4B |
| Operating income | $58.9B | $85.1B | $75.5B | $87.1B | $72.3B |
| Net income | $7.47B | $31.7B | $42.4B | $54.3B | $37.3B |
| EPSd | $23.6M | $96.3M | $126.7M | $161M | $108.2M |
| Operating cash flow | $98.6B | $138.3B | $129.3B | $51.7B | $78.2B |
| Capital expenditure | -$-97.66B | -$-75.78B | -$-60.55B | -$-72.66B | -$-70.18B |
| Free cash flow | $936M | $62.5B | $68.7B | -$-20.93B | $8.04B |
| Total assets | $1.3T | $1.29T | $1.25T | $1.22T | $1.09T |
| Total debt | $284.9B | $287.3B | $320.2B | $357.5B | $327.5B |
| Net debt | $180.8B | $169.3B | $189.1B | $233.8B | $175.6B |
| Total equity | $755.2B | $781.8B | $736.2B | $668.5B | $579.6B |
| Cash and short-term investments | $108.3B | $121.7B | $134.6B | $128.6B | $155.8B |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $808.4B | $826.9B | $780.9B | $756.4B | $629.4B |
| Cost of revenue | $561.9B | $559.1B | $539.6B | $513.1B | $423.9B |
| Gross profit | $246.5B | $267.7B | $241.4B | $243.3B | $205.4B |
| Research and development expenses | $0.00 | $25.7B | $24.4B | $22.7B | $20.8B |
| Selling, general and administrative expenses | $187.6B | $157B | $141.4B | $133.5B | $112.3B |
| Other expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating expenses | $187.6B | $182.7B | $165.9B | $156.1B | $133.2B |
| Cost and expenses | $749.6B | $741.8B | $705.5B | $669.2B | $557.1B |
| Interest income | $2.26B | $3.42B | $1.84B | $450M | $141M |
| Interest expense | $2.81B | $2.74B | $2.82B | $1.46B | $1.63B |
| Depreciation and amortization | $84.7B | $85.3B | $77.2B | $65.5B | $59B |
| Ebitda | $143.6B | $170.3B | $152.6B | $152.6B | $131.3B |
| Operating income | $58.9B | $85.1B | $75.5B | $87.1B | $72.3B |
| Total other income/expenses, net | -$-39.06B | -$-31.91B | -$-14.2B | -$-9.14B | -$-13.56B |
| Income before tax | $19.8B | $53.2B | $61.3B | $78B | $58.7B |
| Income tax expense | $14.8B | $22B | $19B | $22.4B | $20.3B |
| Net income | $7.47B | $31.7B | $42.4B | $54.3B | $37.3B |
| Weighted average shares outstanding | $316.3M | $329.3M | $334.7M | $337.1M | $344M |
| Weighted average diluted shares outstanding | $316.4M | $329.5M | $335M | $337.3M | $344.3M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $108.3B | $121.7B | $134.6B | $128.6B | $155.8B |
| Net receivables | $177.4B | $165.6B | $161B | $156.5B | $135.3B |
| Inventory | $268.4B | $256.8B | $228B | $225B | $157.3B |
| Total current assets | $578.4B | $565.3B | $551.7B | $533.9B | $470.2B |
| Property, plant and equipment, net | $549.1B | $540.4B | $527B | $512.6B | $455.3B |
| Goodwill and intangible assets | $110.6B | $115.9B | $120.5B | $121.5B | $114.1B |
| Long-term investments | $23.5B | $29.9B | $24B | $23.3B | $25.8B |
| Total non-current assets | $725.1B | $726B | $702.8B | $687.6B | $620.8B |
| Total assets | $1.3T | $1.29T | $1.25T | $1.22T | $1.09T |
| Accounts payable | $58.5B | $59.6B | $49.1B | $52.7B | $49.6B |
| Short-term debt | $88.7B | $58.5B | $69.8B | $89.2B | $91.4B |
| Deferred revenue | $0.00 | $3.43B | $9.25B | $5.98B | $0.00 |
| Total current liabilities | $228.2B | $198.2B | $200.6B | $221.3B | $219.5B |
| Long-term debt | $196.2B | $228.9B | $250.5B | $268.3B | $236.1B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $320.1B | $311.2B | $317.8B | $331.7B | $291.9B |
| Capital lease obligations | $0.00 | $36.6B | $33.1B | $28.8B | $18.2B |
| Total liabilities | $548.3B | $509.4B | $518.3B | $553B | $511.4B |
| Common stock | $89B | $89B | $89B | $89B | $89B |
| Retained earnings | $386.9B | $396.8B | $426.3B | $399.9B | $359.9B |
| Accumulated other comprehensive income (loss) | $212.7B | $192.9B | $137.9B | $96.8B | $40.3B |
| Total equity | $755.2B | $781.8B | $736.2B | $668.5B | $579.6B |
| Total investments | $27.7B | $33.5B | $27.5B | $28.1B | $29.6B |
| Total debt | $284.9B | $287.3B | $320.2B | $357.5B | $327.5B |
| Net debt | $180.8B | $169.3B | $189.1B | $233.8B | $175.6B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $7.47B | $31.7B | $42.4B | $54.3B | $37.3B |
| Depreciation and amortization | $84.7B | $85.3B | $77.2B | $65.5B | $59B |
| Stock-based compensation | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in working capital | -$-11.82B | -$-466M | $17.2B | -$-69.31B | -$-5.35B |
| Accounts receivable | -$-8.85B | $2.2B | $2.11B | -$-12.5B | -$-13.44B |
| Inventory | -$-6.33B | -$-17.26B | $8.36B | -$-54.72B | -$-17.54B |
| Accounts payable | -$-1.33B | $6.24B | -$-5.12B | $691M | $12.2B |
| Net cash provided by operating activities | $98.6B | $138.3B | $129.3B | $51.7B | $78.2B |
| Investments in property, plant and equipment | -$-97.66B | -$-75.78B | -$-60.55B | -$-72.66B | -$-70.18B |
| Acquisitions, net | $0.00 | $0.00 | $214M | $1.12B | $1.91B |
| Net cash used for investing activities | -$-98.13B | -$-76.01B | -$-63.15B | -$-68.12B | -$-63.78B |
| Common stock issued | $0.00 | $0.00 | $0.00 | $0.00 | $82M |
| Common stock repurchased | -$-30B | -$-20B | -$-4M | -$-10B | -$-2M |
| Dividends paid | -$-17.37B | -$-17.29B | -$-16.07B | -$-13.91B | -$-13.41B |
| Net cash used for financing activities | -$-16.31B | -$-82.5B | -$-64.96B | -$-12.56B | -$-49.27B |
| Net change in cash | -$-17.59B | -$-11.97B | $6.05B | -$-23.87B | -$-30.6B |
| Cash at end of period | $104.1B | $121.7B | $133.7B | $127.6B | $151.5B |
| Operating cash flow | $98.6B | $138.3B | $129.3B | $51.7B | $78.2B |
| Capital expenditure | -$-97.66B | -$-75.78B | -$-60.55B | -$-72.66B | -$-70.18B |
| Free cash flow | $936M | $62.5B | $68.7B | -$-20.93B | $8.04B |
Line items
Line items
Line items
About Kuraray Co., Ltd.
Kuraray Co., Ltd. engages in the production and sale of resins, chemicals, fibers, activated carbon, and high-performance membranes and systems worldwide. The Vinyl Acetate segment manufactures and markets functional resins and films, including PVA, PVB and EVAL. The Isoprene segment engages in the manufacture and marketing of SEPTON thermoplastic elastomer, isoprene-related products, and GENESTAR. The Functional Materials segment manufactures and markets methacrylic resin, medical products, and carbon materials. The Fibers and Textiles segment manufactures and sells synthetic fibers and textiles, CLARINO manmade leather, non-woven fabrics, and other products. The Trading segment mainly processes and sells synthetic fibers and manmade leathers. The company was founded in 1926 and is headquartered in Tokyo, Japan.
- CEO
- Hitoshi Kawahara
- Employees
- 11.94K
- Beta
- 0.05
Included in
Explore
Frequently asked questions
What is the intrinsic value of Kuraray Co., Ltd. (3405.T)?
InvestorsCraft does not currently publish an intrinsic value for 3405.T. How the IC value is calculated.
Is 3405.T undervalued?
InvestorsCraft does not publish an undervaluation signal for 3405.T at this time.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.